Gilead Sciences has announced findings from two studies that support the further development of GS-6207, a novel, selective, first-in-class inhibitor of HIV-1 capsid function, for potential future use as part of long-acting HIV combination therapy. […]
GE Healthcare announces a digital data exchange collaboration program with Amgen, which will include advanced data analytics to increase the understanding of the relationship between raw material variability and process performance during the manufacture of […]
SMi’s 2nd annual Injectable Drug Delivery Conference is returning to London on the 15th and 16th May 2019. SMi Group are delighted to have Dr Joël Richard chairing the two-day conference. Dr Richard is presently […]
SMi reports: An exclusive interview with DalmaSugár, Global Medical Affairs Director, Reckitt Benckiser just ahead of SMi’s 19thAnnual Pain Therapeutics Conference, taking place this May in London. SMi Group are delighted to host the exclusive […]
Global pharmaceutical leader Eli Lilly has announced plans to launch an authorised generic version of its insulin injection Humalog in a bid to offer diabetes patients a cheaper treatment option. Lilly’s lower-priced insulin medication will […]